In the published article, there was an error in the author list. The symbol indicating which authors shared co-first authorship was erroneously missed. The corrected author list appears below, using the symbol † to define which authors share first authorship.
Maohua Rao1†, Yirui Wang1†, Jianli Ren2, Yue Chen3, Chenxi Zheng1, Yalan Xiong1, Qingbo Yan1, Shiying Li4*and Gengbiao Yuan1*
The authors apologize for this error and state that this does not change the scientific conclusions of the article in anyway. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
thyroid, severe liver dysfunction, artificial liver support system, radioiodine, therapeutics
Citation
Rao M, Wang Y, Ren J, Chen Y, Zheng C, Xiong Y, Yan Q, Li S and Yuan G (2023) Corrigendum: Effect of 131 I with and without artificial liver support system in patients with Graves’ disease and severe liver dysfunction: A retrospective study. Front. Endocrinol. 14:1136544. doi: 10.3389/fendo.2023.1136544
Received
03 January 2023
Accepted
10 February 2023
Published
22 February 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2023
Updates
Copyright
© 2023 Rao, Wang, Ren, Chen, Zheng, Xiong, Yan, Li and Yuan.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shiying Li, 302946@hospital.cqmu.edu.cn; Gengbiao Yuan, 300784@hospital.cqmu.edu.cn
†These authors have contributed equally to this work and share first authorship
This article was submitted to Thyroid Endocrinology, a section of the journal Frontiers in Endocrinology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.